AssetMark Inc
KURA icon

AssetMark Inc’s Kura Oncology KURA Stock Holding History

AssetMark Inc’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18
Closed -$1K – 1447
2021
Q1 		$1K Hold
18
– – ﹤0.01% 1268
2020
Q4 		$1K Sell
18
-13
-42% -$457 ﹤0.01% 1319
2020
Q3 		$1K Hold
31
– – ﹤0.01% 1243
2020
Q2 		$1K Sell
31
-19
-38% -$274 ﹤0.01% 1182
2020
Q1 		$0 Sell
50
-23
-32% -$263 ﹤0.01% 1461
2019
Q4 		$1K Hold
73
– – ﹤0.01% 1319
2019
Q3 		$1K Buy
+73
New +$1.3K ﹤0.01% 1243

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

AssetMark Inc's KURA Position: Q2 2021 in Review

AssetMark Inc sold out of Kura Oncology (KURA) in Q2 2021, closing a stake of 18 shares — an estimated $1K sold.

AssetMark Inc first reported a position in KURA in Q3 2019 and held it in 7 quarters. The position peaked at $1K in Q1 2021. 171 funds tracked by Wall St. Rank hold KURA as of Q2 2021.

  • AssetMark Inc reported no remaining Kura Oncology position as of Q2 2021 after selling out during the quarter.
  • AssetMark Inc sold 18 Kura Oncology shares in Q2 2021, an estimated $1K.
  • AssetMark Inc first reported a position in Kura Oncology in Q3 2019 and held it in 7 quarters.
  • AssetMark Inc's Kura Oncology position peaked at $1K in Q1 2021.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2021.

Based on AssetMark Inc's 13F filing for Q2 2021, filed 16 Aug 2021.